CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
9 hedge funds and large institutions have $4.89M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$353K | |
| 2 | +$258K | |
| 3 | +$17K | |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
+$12.6K |
| 5 |
Morgan Stanley
New York
|
+$2K |
Top Sellers
| 1 | -$888K | |
| 2 | -$257K | |
| 3 | -$59.1K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$24K |
| 5 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
-$1K |